CEO · Founder, Gelomics
| Role | Organisation | Sources |
|---|---|---|
| CEO · Founder | Gelomics | Startup Daily (5 Jul 2024), Startup Daily (14 Aug 2023) |
Stories naming Dr Christoph Meinert. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Brisbane biotech Gelomics has raised a pre-seed round to advance its animal-free tissue testing technology, with Jelix Ventures leading and QIC's Enterprise Acceleration Fund and Angelloop participating.
Jelix's investment note explains why its fund led Gelomics's seed round, with QIC and Angelloop participating; the startup grows 3D cell cultures for biomedical research and drug development.
Partner content profiling Gelomics, a Brisbane biotech whose 3D tissue culture technology now reaches over 200 labs internationally, crediting a Queensland government export grant with helping it win its first Japanese customers.